K Datta Associate Director and HOD, Department of Emergency Medicine Max Hospital, Shalimar Bagh, New Delhi 110088, India
Uzma Khanam MEM Resident, Department of Emergency Medicine Max Hospital, Shalimar Bagh, New Delhi 110088, India
Pallavi Verma MEM Resident, Department of Emergency Medicine Max Hospital, Shalimar Bagh, New Delhi 110088, India
Address for correspondence: K Datta, Associate Director and HOD, Department of Emergency Medicine Max Hospital, Shalimar Bagh, New Delhi 110088, India E-mail: Kishalay.Datta@maxhealtcare.com
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Uzma Khanam, K Datta, Pallavi Verma/ Unusual Presentation of A Covid Patient With Thrombo-Embolism With Survival/J Cardiovasc Med Surg.2022;8(1): 21-24.
Timeline
Received : February 10, 2022
Accepted : March 12, 2022
Published : March 30, 2022
Abstract
Corona virus disease 2019 (COVID-19) is a viral illness caused by a novel corona virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic that has affected >188 countries, involved >24 million people, and caused >840,000 deaths. COVID-19, in its severe form, presents as acute respiratory distress syndrome (ARDS), shock, and multiorgan failure. Thrombotic microangiopathy of the lungs and kidneys has been observed in these patients. Elevated D-dimer levels have been observed in people with serious COVID-19 illness, and this could be helpful in guiding treatment with anticoagulation in these patients.
References
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Corona virus Investigating and Research Team. A novel corona virus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. https://doi.org/10.1056/NEJMoa2001017.
2. Corona viruses. (1 May 2020). Retrieved from https://www.niaid.nih.gov/diseases-conditions/ coronaviruses. Accessed 6 May 2020.
3. Klok FA, Kruip M, van der Meer N, Arbous MS, Gommers D, Kant KM, Kaptein F, van Paassen J, Stals M, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Res. 2020;S0049– 3848(20):30120–1. Advance online publication. https://doi.org/10.1016/j.thromres.2020.04.013.
4. Atallah B, Mallah SI, AlMahmeed W. Anticoagulation in COVID-19. European heart journal cardiovascular pharmacotherapy, pvaa036. 2020. Advance online publication. https://doi. org/10.1093/ehjcvp/pvaa036.
5. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in corona virus infected patients: COVID-19, SARS-CoV-1, MERS-CoV, and lessons from the past. J Clin Virol. 2020;127:104362. Advance online publication. https://doi.org/10.1016/j. jcv.2020.104362.
6. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MC, Bouman CC, Beenen LF, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020. Accepted author manuscript; https://doi.org/10.1111/jth.14888.
7. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Alexia B, Sandri MT, Barco S. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Res. 2020;191:9–14. Advance online publication. https:// doi.org/10.1016/j.thromres.2020.04.024.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Uzma Khanam, K Datta, Pallavi Verma/ Unusual Presentation of A Covid Patient With Thrombo-Embolism With Survival/J Cardiovasc Med Surg.2022;8(1): 21-24.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Description: Segmental left lower lobe and right upper lobe PE. Segmental bilateral embolisms (arrows) can be appreciated in axial (a, b) and oblique MIP and VR images (e, f) over a moderate-severe (score 3) pulmonary involvement (d). Signs of right cardiac overload (black arrow) with interventricular septum shifting towards the left ventricle are shown in c.